
Dr.ย Jiafuย Ji
MD, PhD, FACS, Academician (Chinese Academy of Engineering)
Chief Physician & Professor, Surgical Oncology
corporate_farePeking University Cancer Hospital, Beijing
Jiafu Ji
MD, PhD, FACS, Academician (Chinese Academy of Engineering)
Prof. Jiafu Ji is one of China's foremost authorities on gastric cancer surgery and multidisciplinary gastric cancer management. He is a Chief Physician, Professor, Doctoral Supervisor, and Academician of the Chinese Academy of Engineering, affiliated with Peking University Cancer Hospital in Beijing.
Prof. Ji has dedicated his career to advancing the surgical and comprehensive treatment of gastric cancer in China and internationally. His work has centred on building an integrated gastric cancer care system that combines precision surgery, perioperative chemotherapy, and immunotherapy strategies. He has published 298 SCI papers โ including contributions to JAMA, Science, Cell, PNAS, The Lancet Oncology, and Nature Medicine โ with more than 27,000 citations and an H-index of 73. Prof. Ji has led the formulation of 23 gastric cancer guidelines and expert consensus documents, including China's first national gastric cancer clinical practice guideline, and founded the Chinese Journal of Cancer Research (SCI-indexed).
CancerFax can coordinate medical-record review and consultation support for international patients seeking an expert opinion from Prof. Ji, subject to hospital availability and case acceptance.
Why Consider Prof. Jiafu Ji?
Prof. Ji offers patients with gastric cancer access to one of China's most experienced surgical oncology teams, with a track record in high-impact clinical research and national guideline development.
Areas of Specialisation
Gastric cancer surgery, precision oncology, and comprehensive gastrointestinal tumour management
Prof. Ji's clinical and research work spans the full spectrum of gastric cancer care โ from surgical planning and precision gastrectomy to perioperative systemic therapy and immunotherapy strategy development.
Gastric Cancer Surgery
Surgical management of gastric cancer at all stages, including precision approaches and standardised D2 gastrectomy.
- arrow_rightOpen D2 gastrectomy for gastric adenocarcinoma
- arrow_rightLaparoscopic distal gastrectomy for locally advanced gastric cancer
- arrow_rightRandomised clinical trial evaluation of laparoscopic versus open approaches
- arrow_rightPrecision surgery systems tailored to tumour location and stage
- arrow_rightSurgical planning informed by molecular and pathological profiling
- arrow_rightIntegration of perioperative systemic therapy into surgical pathways
Perioperative & Systemic Treatment
Combined surgical and systemic approaches to optimise outcomes for patients with resectable and locally advanced gastric cancer.
- arrow_rightAdjuvant capecitabine plus oxaliplatin regimens after D2 gastrectomy (CLASSIC programme)
- arrow_rightNeoadjuvant and adjuvant treatment planning for locally advanced disease
- arrow_rightMultidisciplinary coordination of chemotherapy and surgical timing
- arrow_rightDevelopment of immunotherapy-based treatment strategies for gastric and GEJ adenocarcinoma
- arrow_rightPD-1/CTLA-4 dual-target approaches in combination with chemotherapy
- arrow_rightBiomarker-informed patient selection for immune checkpoint therapy
Translational Research & Diagnostics
Gastric cancer biobank leadership, precision medicine infrastructure, and disease monitoring.
- arrow_rightLeadership of the Gastrointestinal Tumour Translational Research Laboratory
- arrow_rightDevelopment of large-scale gastric cancer biobank and clinical database
- arrow_rightPrecision medicine approaches underpinning collaborative clinical research
Procedures Performed
Surgical and multidisciplinary clinical services for gastric and gastrointestinal cancers
Prof. Ji's clinical work encompasses the surgical and systemic treatment of gastric cancer, with emphasis on precision gastrectomy, multidisciplinary care planning, and second-opinion consultations for complex cases.
Gastric Cancer Surgery
Complex DiseaseSurgical resection and reconstruction for gastric and gastrointestinal tumours, including open and laparoscopic approaches.
Perioperative Treatment Planning
Medical OncologyCoordinated pre- and post-operative systemic therapy to improve surgical outcomes.
Multidisciplinary Tumour Board
MultidisciplinaryComprehensive case review integrating surgery, oncology, pathology, and radiology for complex gastric cancer.
Second Opinion for Gastric Cancer
Second OpinionExpert independent review of pathology, surgical plan, and treatment history for gastric cancer cases.
Research & Publications
International-impact gastric cancer research and national guideline development
Prof. Ji has 298 SCI publications with more than 27,000 citations (H-index 73), including papers in JAMA, Science, Cell, PNAS, The Lancet Oncology, and Nature Medicine. He has 9 highly cited papers and has led the formulation of 23 clinical guidelines and expert consensus documents for gastric cancer management in China.
A full publication list is available via Prof. Ji's Google Scholar and ORCID profiles. CancerFax can assist international patients in understanding relevant research when coordinating case submissions.
Education & Training
Prof. Ji trained in China and undertook international postdoctoral and doctoral study in the United States and United Kingdom, building a career spanning clinical surgical oncology and translational research leadership.
Clinical Experience
Prof. Ji has spent the bulk of his career at Peking University Cancer Hospital, where he has risen to the most senior clinical and research leadership roles in gastric cancer surgery in China.
Languages & International
Prof. Ji consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients. English is used in Prof. Ji's academic work; patient consultation language should be confirmed with the hospital.
CancerFax can coordinate professional medical interpreter support for international patients requiring consultations in English or other languages.
How CancerFax Helps You Access Dr. Jiafu Ji
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Jiafu Ji's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Jiafu Ji's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Jiafu Ji before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Jiafu Ji's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Jiafu Ji's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Jiafu Ji's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Jiafu Ji
Prof. Ji specialises primarily in gastric cancer (stomach cancer) and gastrointestinal tumours, with a strong focus on surgical management, precision gastrectomy, perioperative chemotherapy, and multidisciplinary treatment planning. He has particular expertise in locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Prof. Ji is affiliated with Peking University Cancer Hospital in Beijing, China โ one of China's major dedicated cancer centres. He is listed as a Chief Physician, Professor, and Doctoral Supervisor within the Gastrointestinal Tumour Centre, and serves as Director of the Gastrointestinal Tumour Translational Research Laboratory.
Submit your medical reports through CancerFax using the 'Send Your Reports' button. The CancerFax team will review your case, prepare a structured summary, and coordinate the next steps with the hospital, subject to Prof. Ji's availability and case acceptance by the institution.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging (CT, PET-CT, endoscopy), surgical history, and treatment records. The format and availability of the consultation depend on Peking University Cancer Hospital's international patient protocols. CancerFax will coordinate the process.
Prof. Ji is known for D2 gastrectomy (open and laparoscopic), precision gastric cancer surgery, and the integration of perioperative chemotherapy into surgical pathways. His published randomised clinical trial work has contributed to evidence supporting laparoscopic gastrectomy for locally advanced gastric cancer.
Peking University Cancer Hospital is a major academic cancer centre with an international patient profile. CancerFax can coordinate medical-record submission, case review, and appointment support for international patients. Teleconsultation availability and appointment timelines should be confirmed directly through CancerFax or the hospital's international patient office.
Connect with Jiafu Ji Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.